Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$500K Buy
3,894
+692
+22% +$81K 0.33% 27
2026
Q1
$385K Hold
3,202
0.29% 26
2025
Q4
$337K Hold
3,202
0.24% 28
2025
Q3
$269K Hold
3,202
0.21% 31
2025
Q2
$253K Buy
3,202
+2,300
+255% +$183K 0.2% 29
2025
Q1
$81K Sell
902
-316
-26% -$29.5K 0.07% 51
2024
Q4
$121K Buy
1,218
+316
+35% +$32.6K 0.11% 40
2024
Q3
$102K Sell
902
-340
-27% -$40.4K 0.09% 44
2024
Q2
$156K Buy
1,242
+42
+4% +$5.41K 0.14% 35
2024
Q1
$153K Hold
1,200
0.14% 38
2023
Q4
$123K Hold
1,200
0.12% 42
2023
Q3
$124K Hold
1,200
0.13% 42
2023
Q2
$138K Hold
1,200
0.13% 42
2023
Q1
$127K Hold
1,200
0.14% 46
2022
Q4
$132K Sell
1,200
-25
-2% -$2.56K 0.14% 49
2022
Q3
$105K Hold
1,225
0.12% 52
2022
Q2
$112K Hold
1,225
0.13% 54
2022
Q1
$100K Hold
1,225
0.1% 57
2021
Q4
$94K Sell
1,225
-86
-7% -$6.85K 0.09% 68
2021
Q3
$98K Hold
1,311
0.11% 63
2021
Q2
$102K Buy
1,311
+173
+15% +$12.9K 0.11% 62
2021
Q1
$84K Buy
+1,138
New +$83.9K 0.1% 65

Other funds holding MRK

Hoese & Co's MRK Position: Q2 2026 in Review

Hoese & Co increased its Merck (MRK) stake by 22% in Q2 2026, buying an estimated $81K and bringing the position to 3,894 shares worth $500K. The position accounts for 0.33% of the portfolio, ranked #27.

Hoese & Co first reported a position in MRK in Q1 2021 and has held it in 22 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hoese & Co held 3,894 shares of Merck worth $500K as of Q2 2026.
  • Hoese & Co bought 692 Merck shares in Q2 2026, an estimated $81K.
  • Merck made up 0.33% of Hoese & Co's portfolio in Q2 2026, its #27 holding.
  • Hoese & Co first reported a position in Merck in Q1 2021 and has held it in 22 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.